-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
G1 Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
- G1 Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was -74.8 %, a 66.5% increase year-over-year.
- G1 Therapeutics, Inc. annual Return On Equity for 2023 was -106 %, a 49.5% increase from 2022.
- G1 Therapeutics, Inc. annual Return On Equity for 2022 was -210 %, a 176% decline from 2021.
- G1 Therapeutics, Inc. annual Return On Equity for 2021 was -76 %, a 54.8% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)